# Symptoms and stages of metastatic breast cancer
Metastatic breast cancer (metastatic breast cancer) does not progress in strictly defined 'stages' as is sometimes thought. It is rather a chronic disease process with much individual variation, depending on where the metastases are located, what type of breast cancer it is, and how the body responds to treatment. Yet there are patterns in symptoms and the way the course typically unfolds.
The moment of diagnosis: metastases discovered
If breast cancer is first diagnosed as metastatic, or if metastases appear after previously treated breast cancer, that is a turning point. Some people notice symptoms that prompt them to seek examination; others are incidentally confronted with metastases on follow-up scans without having noticed much.
**What happens in the body:**
The cancer cells have spread via blood or lymph vessels to other organs, usually bone, lungs, liver or brain. These new tumors are biologically identical to the original breast cancer, but now grow in places where they cause much more disruption.
**Symptoms at the time of discovery:**
This depends heavily on where the metastases are located:
- **Bone metastases** (most common): diffuse or localized bone pain, especially in spine, pelvis and thighbone; weakness and fatigue.
- **Lung metastases**: persistent cough, shortness of breath, sometimes chest pain on deep breathing.
- **Liver metastases**: pain in upper right abdomen, bloating, nausea, decreased appetite.
- **Brain metastases**: headache, dizziness, concentration problems, sometimes seizures or motor problems.
In this phase, clinicians search for answers: what mutations does the tumor have, and which treatment fits best? This can take several weeks, which feels like an intense information storm.
**What it means for daily life:**
Much uncertainty. Tests and conversations with doctors take up much time. Physically you sometimes still feel relatively well, but emotionally it is intense. Some people can still work fully; others feel tired and anxious and need more rest.
**Numbers:**
For metastatic breast cancer, survival rates are highly dependent on the subtype (hormone-dependent vs. HER2-positive vs. triple-negative), the number and location of metastases, and age. For hormone-dependent metastatic breast cancer, median survival worldwide is approximately 2–3 years, but many patients live considerably longer (data: SEER, American Cancer Society, 2020–2023). For HER2-positive metastases this can be longer thanks to targeted medication. Triple-negative metastases typically have a shorter outlook. These figures are population averages; individual prognoses can differ much more widely and depend on many factors that are unique to each person.
The stabilization phase: under treatment
Once treatment begins (hormone therapy, chemotherapy, targeted medication, immunotherapy or a combination), a period of 'waiting for response' usually sets in. This typically lasts 6–12 weeks before scanning.
**Symptoms from the disease itself:**
- Pain may slowly decrease or stabilize.
- Fatigue and weakness may decrease as tumor growth slows.
- Cough or shortness of breath may decrease.
- In some people symptoms remain stably the same.
**Symptoms from treatment:**
This depends heavily on what kind of medication is given. Many patients experience:
- Chemotherapy: nausea, hair loss, susceptibility to infection, bowel complaints.
- Hormone therapy: hot flashes, dryness, weight gain, lack of interest.
- Targeted medication (e.g. HER2 inhibitors, CDK4/6 inhibitors): fatigue, skin problems, diarrhea.
- Immunotherapy: episodes of flu-like symptoms, diarrhea, sometimes more serious inflammation.
**What it means for daily life:**
This is a phase of 'rhythmic living': treatment days (taking pills or infusions), recovery days, monitoring periods. Working is sometimes possible, especially with oral medicines, but many people take leave or go part-time. Appetite can be unpredictable. Many people feel 'in waiting' – hopeful about response, but also anxious.
**Numbers:**
If the disease responds to treatment (complete or partial remission on scan), survival is usually longer than if the disease grows immediately. For hormone-dependent metastases with CDK4/6 inhibitors plus hormone therapy, studies report median progression-free survivals of 20–30 months (MONALEESA, PALOMA studies, 2018–2023). This means the median time until further growth is that long, not that you stop living after that. For HER2-positive metastases with modern combinations, progression-free periods of 1–2 years or longer can be achieved. With triple-negative cancer, response is often shorter. Again: these numbers apply on average; many patients remain stable longer.
The phase of progression: when treatment becomes less effective
After months to years, the tumor may begin to grow despite treatment, or new metastases may develop. This moment of 'progression' is detected via scans or because symptoms change.
**Symptoms:**
- The earlier symptoms (pain, shortness of breath, etc.) increase again.
- New locations can cause pain or other complaints.
- Fatigue becomes deeper.
- Appetite disappears further.
- Mentally, many people feel disappointment and fear.
**Switching treatment:**
Now follows a new conversation with the doctor about a next treatment. This can be another medication, chemotherapy, radiotherapy on painful spots, or a combination. This sometimes happens multiple times.
**What it means for daily life:**
This is a mentally difficult phase. You may have lived stable for some time, and now the tumor is growing again. Some patients switch treatments faster (to prevent the tumor from becoming resistant); others have more rest between treatments. Many people report increased anxiety, sometimes depression. Work usually becomes impossible. Caring for yourself (eating, sleeping, hygiene) requires more effort.
**Numbers:**
The time between progression and next stabilization varies greatly. With recurrent hormone-dependent cancer, the 2nd or 3rd hormone tablet can again give 1–2 years of stability. Chemotherapy can give a few months of response in non-responding tumors. Triple-negative cancer usually has shorter intervals. The longer you have been ill, the more clinically complex it becomes. At the population level, patients with multiple previous treatments have shorter survival than first-line patients, but individual outliers vary greatly (data: various first-line vs. later-line trials, 2020–2026).
The phase of advanced disease: many symptoms, many limitations
This is not one sharp moment, but rather a gradual process in which symptoms become more complex and treatment options more limited.
**Symptoms:**
This depends on where the tumor grows:
- **Bone metastases**: increasing pain, sometimes fracture risk, immobility.
- **Brain metastases**: headache, blurred vision, confusion, sometimes seizures.
- **Liver metastases**: bloating (ascites), toilet use, icterus (jaundice).
- **Lung metastases**: severe shortness of breath, cough, sometimes coughing up blood.
- **General**: severe fatigue ('cancer fatigue'), weight loss, disturbed sleep, pain crises.
**Treatment:**
In this phase, symptom management is central. Radiotherapy on painful spots, palliative chemotherapy in low doses, strong painkillers, anti-nausea medications, oxygen therapy. Many patients speak with their doctor around this time about palliative care and what their wishes are.
**What it means for daily life:**
Much of the day goes to symptom management: taking medications, attending appointments, dealing with pain and fatigue. Self-care becomes heavier. Many patients withdraw, want to be at home. Friends and family are now essential. Many people feel fear, but also a kind of acceptance.
**Numbers:**
Life expectancy in this phase varies from months to sometimes a year or more, depending on the specific situation. Patients with brain metastases have without treatment typically a very short survival (weeks), but treatment (radiotherapy, targeted medicines) can extend this. Those with only bone metastases can live for years. This phase has no fixed timeline; it is very different for each person.
The final phase: palliative care and grief
When it becomes clear that curative treatment is no longer possible, or when symptoms become unmanageable despite everything, many teams switch to 'end-of-life care'. This is not the same as 'doing nothing' – it is a different kind of care, focused on comfort and dignity.
**Symptoms:**
- Extremely tired, lots of sleep.
- Reduced awareness.
- Changes in breathing, heart rate.
- Pain may still be present (but is now actively managed).
- Sometimes restlessness or confusion.
**What it means:**
This is an intimate, private process, usually at home or in a hospice. Family is close by. Doctors and nurses focus on comfort, listen, and provide support.
**No numbers here** – this is the end of the journey, very personal and unique.
Warning signs: when to contact your doctor
Contact as soon as possible (same day or next day) in case of:
- Sudden severe pain that your medicines do not help.
- Severe shortness of breath or chest pain.
- Confusion, headache or seizures (may indicate brain metastases).
- Fever above 38.5 °C (infection risk from chemotherapy).
- Severe bleeding.
- Abdominal pain with vomiting (may indicate obstruction).
- Sudden loss of feeling or movement in legs (may be spinal compression).
- Severe depression or suicidal thoughts.
_This information never replaces a doctor's judgment. Always discuss your situation with your own healthcare provider._